A detailed history of Signature Estate & Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Signature Estate & Investment Advisors LLC holds 6,058 shares of ABBV stock, worth $1.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,058
Previous 6,018 0.66%
Holding current value
$1.09 Million
Previous $1.03 Million 15.89%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $6,553 - $7,973
40 Added 0.66%
6,058 $1.2 Million
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $662,346 - $773,472
4,279 Added 246.06%
6,018 $1.03 Million
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $23,973 - $27,315
150 Added 9.44%
1,739 $316,000
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $17,062 - $19,216
-124 Reduced 7.24%
1,589 $246,000
Q3 2023

Oct 25, 2023

SELL
$133.59 - $154.65 $2,271 - $2,629
-17 Reduced 0.98%
1,713 $256,000
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $3,445 - $4,287
-26 Reduced 1.48%
1,730 $233,000
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $16,774 - $19,318
-116 Reduced 6.2%
1,756 $280,000
Q4 2022

Jan 11, 2023

SELL
$138.31 - $165.87 $60,303 - $72,319
-436 Reduced 18.89%
1,872 $303,000
Q3 2022

Oct 20, 2022

SELL
$134.21 - $153.93 $13,421 - $15,393
-100 Reduced 4.15%
2,308 $309,000
Q2 2022

Jul 13, 2022

SELL
$137.62 - $174.96 $17,202 - $21,870
-125 Reduced 4.93%
2,408 $368,000
Q1 2022

Apr 19, 2022

BUY
$131.98 - $163.75 $41,045 - $50,926
311 Added 14.0%
2,533 $410,000
Q4 2021

Jan 20, 2022

SELL
$107.43 - $135.93 $6,875 - $8,699
-64 Reduced 2.8%
2,222 $301,000
Q3 2021

Oct 12, 2021

SELL
$106.4 - $120.78 $35,750 - $40,582
-336 Reduced 12.81%
2,286 $246,000
Q2 2021

Jul 16, 2021

BUY
$105.21 - $117.21 $21,357 - $23,793
203 Added 8.39%
2,622 $296,000
Q1 2021

Apr 15, 2021

BUY
$102.3 - $112.62 $25,575 - $28,155
250 Added 11.53%
2,419 $262,000
Q4 2020

Jan 13, 2021

BUY
$80.49 - $108.67 $26,803 - $36,187
333 Added 18.14%
2,169 $232,000
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $6,924 - $8,664
96 Added 5.52%
1,836 $162,000
Q3 2019

Oct 31, 2019

BUY
$62.98 - $75.72 $9,824 - $11,812
156 Added 9.85%
1,740 $132,000
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $3,285 - $4,199
-50 Reduced 3.06%
1,584 $115,000
Q4 2018

Feb 01, 2019

BUY
$77.85 - $96.01 $35,266 - $43,492
453 Added 38.36%
1,634 $151,000
Q3 2018

Oct 18, 2018

BUY
$88.91 - $98.84 $105,002 - $116,730
1,181 New
1,181 $112,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Signature Estate & Investment Advisors LLC Portfolio

Follow Signature Estate & Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Estate & Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Estate & Investment Advisors LLC with notifications on news.